Outcomes and progression
Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer
8
Predicting disease progression and poor outcomes in patients with moderately active rheumatoid arthritis: a systematic review
10
Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over time
7
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab
8
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model
12
Evaluation of preoperative speed of progression and its association with surgical outcomes in primary congenital glaucoma patients: a retrospective study
6
Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients
9
Effect of Four Approaches to Oral Feeding Progression on Clinical Outcomes in Preterm Infants
9
Original Article A high expression of MTERF3 correlates with tumor progression and predicts poor outcomes in patients with brain glioma
12
P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy
10
Progression of Blood Pressure and Cardiovascular Outcomes in Hypertensive Patients in a Reference Center
7
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes
16
RE Progression. RE Progression of Skills and Knowledge Page 1
7
Women’s Progression in the Workplace
93
RE Skills Progression
11
History Progression. Year 3 OUTCOMES
5
Flotillin 2 is associated with breast cancer progression and poor survival outcomes
10
Metalloproteinases in the pathogenesis and progression of metabolic syndrome: potential targets for improved outcomes
9
Progression of CKD form pre-dialysis : natural course, risk factors, and outcomes
140
Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
10